ALLMedicine™ Breast Cancer Screening Center

May 21st, 2022 - Breast cancer patients in low- and middle-income countries often present at an advanced stage. This qualitative study elicited views regarding the challenges and opportunities for breast cancer screening and early detection among women in a low-in...

May 20th, 2022 - Breast cancer incidence rates are rising in low and middle-income countries (LMIC), and these populations have reduced access to advanced multidisciplinary treatment. Screening and early detection are therefore critical in these regions but must b...

May 18th, 2022 - In the COVID-19 pandemic, fear of coronavirus infection has caused individuals to hesitate to access medical services and postpone their participation in diagnostic and screening programs. With this research, it was aimed to examine the relationsh...

May 18th, 2022 - Background Mammographic breast density and benign breast disease are strong risk factors for breast cancer. Accordingly, women with both risk factors may have a markedly high risk for developing breast cancer. Purpose To investigate the risk of br...

May 17th, 2022 - This systematic review and meta-analysis focuses on breast cancer screening performance outcomes stratified into breast density, age, and reading procedure using 'digital breast tomosynthesis (DBT) with synthesised two-dimensional mammography (s2D...

Nov 20th, 2021 - Mammography remains the only validated screening tool for breast cancer, however, there are limitations to mammography. One of the limitations of mammography is the variable sensitivity based on breast density. Supplemental screening may be consid...

Nov 20th, 2021 - Breast cancer screening recommendations for transgender and gender nonconforming individuals are based on the sex assigned at birth, risk factors, and use of exogenous hormones. Insufficient evidence exists to determine whether transgender people ...

Nov 26th, 2019 - The European Commission Initiative for Breast Cancer Screening and Diagnosis guidelines (European Breast Guidelines) are coordinated by the European Commission's Joint Research Centre. The target audience for the guidelines includes women, health ...

Apr 9th, 2019 - The purpose of this guidance statement is to provide advice to clinicians on breast cancer screening in average-risk women based on a review of existing guidelines and the evidence they include. This guidance statement is derived from an appraisal...

Nov 18th, 2018 - The NCCN Guidelines for Breast Cancer Screening and Diagnosis have been developed to facilitate clinical decision making. This manuscript discusses the diagnostic evaluation of individuals with suspected breast cancer due to either abnormal imagin...

May 17th, 2022 - Cervical cancer (CC) is preventable. Screening for CC aims to identify treatable lesions prior to the development of invasive CC which, without screening, is often first detected at a stage when comfort care is all that can be offered. Still, only...

Apr 27th, 2022 - To evaluate the safety and efficacy of the proposed investigational device and assess its clinical utility in breast cancer screening and diagnosis to support continuing technology development of the investigational technology.

Apr 20th, 2022 - The AI cancer detection system will act as a 3rd reader and will recall additional cases to the consensus conference: the exams that were not recalled by double reading but are classified as the 3% most suspicious exams, based on AI derived cancer...

Apr 8th, 2022 - Context : Organized breast cancer screening has been introduced in France since 2004. It concerns women aged 50 to 74 years old with average risk (no symptoms and no risk factors). This systematic screening reaches approximately 70% of the includa...

Apr 6th, 2022 - This is a prospective, randomized controlled trial that will evaluate the effectiveness of two different outreach strategies in improving adherence to breast cancer screening via mammography. Average risk female Veterans who are due for breast can...

Mar 30th, 2022 - Breast cancer screening modality has less effect on the probability of false-positive results than screening interval, patient age, and breast density according to a new study comparing digital breast tomosynthesis (DBT) with digital mammography. ...

Mar 25th, 2022 - Breast cancer screening with digital breast tomosynthesis (DBT), or "3D mammography," was associated with a lower probability of false-positive findings compared with standard digital mammography, investigators found. Their comparative effectivene...

Mar 15th, 2022 - We have been interested in the quiz series focused on breast cancer screening for women with dense breasts presented in OBG Management by DenseBreast-Info. org.

Mar 1st, 2022 - NEW YORK (Reuters Health) - About 15% of screen-detected breast cancers among women ages 50-74 would not have caused symptoms or signs in a woman's remaining lifetime, which is less than previously thought, a modeling study suggests. Identificatio...

Feb 28th, 2022 - About one in seven cases of screen-detected breast cancer are overdiagnosed, according to a modeling study based on data from Breast Cancer Surveillance Consortium (BCSC) centers. In a program of biennial screening for women ages 50 to 74, consist...